Bill Status of SB 1625   102nd General Assembly

Short Description:  PHARMACY-PRICE DISCLOSURE

Senate Sponsors
Sen. Doris Turner, Adriane Johnson, Emil Jones, III and Mattie Hunter-Julie A. Morrison

Last Action  View All Actions

DateChamber Action
  1/10/2023SenateSession Sine Die

Statutes Amended In Order of Appearance
225 ILCS 85/41
225 ILCS 85/43 new

Synopsis As Introduced
Amends the Pharmacy Practice Act. Removes a provision limiting consumers to 10 requests for disclosure of the current usual and customary retail price of prescription drugs or medical devices for which the person making the request has a prescription. Provides that a pharmacy must post a notice informing customers that they may request, in person or by telephone, the current usual and customary retail price of any brand or generic prescription drug or medical device that the pharmacy offers for sale to the public. Provides that a pharmacist or his or her authorized employee must disclose to the consumer at the point of sale the current pharmacy retail price for each prescription medication the consumer intends to purchase. If the consumer's cost-sharing amount for a prescription exceeds the current pharmacy retail price, the pharmacist or his or her authorized employee must disclose to the consumer that the pharmacy retail price is less than the patient's cost-sharing amount.

Actions 
DateChamber Action
  2/26/2021SenateFiled with Secretary by Sen. Doris Turner
  2/26/2021SenateFirst Reading
  2/26/2021SenateReferred to Assignments
  3/9/2021SenateAssigned to Licensed Activities
  3/16/2021SenateAdded as Co-Sponsor Sen. Adriane Johnson
  3/16/2021SenateAdded as Co-Sponsor Sen. Emil Jones, III
  3/17/2021SenateAdded as Co-Sponsor Sen. Mattie Hunter
  3/24/2021SenateAdded as Chief Co-Sponsor Sen. Julie A. Morrison
  3/24/2021SenatePostponed - Licensed Activities
  4/16/2021SenateRule 3-9(a) / Re-referred to Assignments
  1/10/2023SenateSession Sine Die

Back To Top